SHIONOGI & CO., LTD.

Analyst Reco. Shionogi & Co., Ltd.

Equities

4507

JP3347200002

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-06-07 am EDT			5-day change	1st Jan Change
6,301 ^JPY	-12.91%		-10.50%	-7.31%

Jun. 07	Japan's Nikkei little changed ahead of key US data, central bank meetings	RE
Jun. 07	Japan's Nikkei edges down ahead of key US data, central bank meetings	RE

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Jefferies Adjusts Shionogi’s Price Target to 7,600 Yen From 6,200 Yen, Keeps at Hold	Mar. 01	MT
Jefferies Adjusts Shinogi & Co’s Price Target to 6,200 Yen From 6,000 Yen, Keeps at Hold	23-08-01	MT
Japan Shares Dip as Investors Eye Bank of Japan's Interest Rate Decision Next Week	23-07-21	MT
Jefferies Adjusts Shionogi's Price Target to 6,000 Yen From 6,300 Yen, Keeps at Hold	23-07-17	MT
Shionogi has been recognized as one of the highest-ranking companies on the Supplier Engagement Rating by CDP	23-03-17	AQ
Factbox-US government to impose inflation penalties on 27 drugs	23-03-15	RE
Nikkei hits over 2-month high on hopes of Fed slowing rate-hike pace	22-11-23	RE
RBC Capital on Bellus Health -- Maintains US$21 PT, Outperform/Speculative Risk Rating	22-11-15	MT
GSK Unit ViiV Healthcare's HIV Prevention Drug Shows Lower Rate Of New Infections Among Women In Clinical Trial	22-07-28	MT
Nikkei 225 : Off 0.6% On China Outlook, Interest Rates, US Futures	21-03-23	MT
Nikkei 225 : Up 0.5%, Extends Rally to Sixth Day on Wall Street Cues, Interest Rates	21-03-16	MT
Shionogi : Gains High Rating in Survey by CDP	20-02-05	AQ
Shionogi & Co., Ltd. Announces Appearance Rate and Clinical Course of Mutated Viruses at Position 38 in Pa Protein for Influenza A/H1N1pdm and A/H3N2 in Special Drug Use Survey for Xofluza	19-09-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer